Wellesley Asset Management
Follow13F filer, CIK 1533551, PORTSMOUTH, NH
Wellesley Asset Management reported $1,095,411,161 across 64 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 33.74% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001533551-26-000004
- Period
- 2026-06-30
- Reported value
- $1.1B
- Holdings
- 64
- Top 10 weight
- 33.74%
- New
- 17
- Sold out
- 7
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001533551-26-000004, largest first. % of portfolio is the value over $1,095,411,161, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| BOX INCBOX INC NOTE 1.500% 9/1 | principal | 49,546,000 | $47M | -1,635,000 |
| ITRON INCITRON INC NOTE 1.375% 7/1 | principal | 44,985,000 | $42.7M | +8,990,000 |
| BLACKLINE INCBLACKLINE INC NOTE 1.000% 6/0 | principal | 42,867,000 | $39.8M | +5,945,000 |
| LIVANOVA PLCLIVANOVA PLC NOTE 2.500% 3/1 | principal | 31,146,000 | $39M | +3,543,000 |
| AEROVIRONMENT INCAEROVIRONMENT INC NOTE 7/1 | principal | 39,025,000 | $37.6M | +31,109,000 |
| HAEMONETICS CORP MASSHAEMONETICS CORP MASS NOTE 2.500% 6/0 | principal | 37,883,000 | $36.6M | -370,000 |
| MERITAGE HOMES CORPMERITAGE HOMES CORP NOTE 1.750% 5/1 | principal | 32,281,000 | $33.2M | -1,691,000 |
| PG&E CORPPG&E CORP NOTE 4.250%12/0 | principal | 32,230,000 | $32.8M | -1,855,000 |
| GREENBRIER COS INCGREENBRIER COS INC NOTE 2.875% 4/1 | principal | 26,998,000 | $30.6M | -1,471,000 |
| SOUTHERN COSOUTHERN CO NOTE 3.250% 6/1 | principal | 30,127,000 | $30.2M | new |
| DOORDASH INCDOORDASH INC NOTE 5/1 | principal | 31,902,000 | $30M | new |
| PARSONS CORP DELPARSONS CORP DEL NOTE 2.625% 3/0 | principal | 30,098,000 | $29.9M | +413,000 |
| MICROCHIP TECHNOLOGY INC.MICROCHIP TECHNOLOGY INC. NOTE 0.750% 6/0 | principal | 27,068,000 | $29.5M | -801,000 |
| GUIDEWIRE SOFTWARE INCGUIDEWIRE SOFTWARE INC NOTE 1.250%11/0 | principal | 31,894,000 | $29M | -340,000 |
| GLOBAL PMTS INCGLOBAL PMTS INC NOTE 1.500% 3/0 | principal | 29,583,000 | $26.8M | -2,530,000 |
| DROPBOX INCDROPBOX INC NOTE 3/0 | principal | 28,266,000 | $26.8M | +5,869,000 |
| TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC NOTE 0.500% 5/1 | principal | 23,551,000 | $26.3M | new |
| MERIT MED SYS INCMERIT MED SYS INC NOTE 3.000% 2/0 | principal | 25,627,000 | $26.1M | new |
| ENVISTA HOLDINGS CORPORATIONENVISTA HOLDINGS CORPORATION NOTE 1.750% 8/1 | principal | 25,263,000 | $25.3M | -156,000 |
| REPLIGEN CORPREPLIGEN CORP NOTE 1.000%12/1 | principal | 25,587,000 | $24.5M | +1,106,000 |
| WINNEBAGO INDS INCWINNEBAGO INDS INC NOTE 3.250% 1/1 | principal | 24,881,000 | $23.4M | -1,636,000 |
| SYNAPTICS INCSYNAPTICS INC NOTE 0.750%12/0 | principal | 15,386,000 | $23.1M | -18,939,000 |
| AKAMAI TECHNOLOGIES INCAKAMAI TECHNOLOGIES INC NOTE 0.375% 9/0 | principal | 19,682,000 | $23.1M | -9,323,000 |
| DATADOG INCDATADOG INC NOTE 12/0 | principal | 16,021,000 | $23M | -14,284,000 |
| EEFT USEEFT US 10/1/2030 | principal | 27,000,000 | $22.7M | new |
| LEMAITRE VASCULAR INCLEMAITRE VASCULAR INC NOTE 2.500% 2/0 | principal | 20,558,000 | $21.1M | +723,000 |
| PROGRESS SOFTWARE CORPPROGRESS SOFTWARE CORP NOTE 3.500% 3/0 | principal | 21,041,000 | $20.9M | -4,980,000 |
| CMS ENERGY CORPCMS ENERGY CORP NOTE 3.375% 5/0 | principal | 20,500,000 | $20.7M | +7,110,000 |
| OMNICELL COMOMNICELL COM NOTE 1.000%12/0 | principal | 20,766,000 | $20.6M | +1,640,000 |
| INTEGER HLDGS CORPINTEGER HLDGS CORP DBCV 1.875% 3/1 | principal | 21,186,000 | $20.5M | new |
| LANTHEUS HLDGS INCLANTHEUS HLDGS INC Convertible | principal | 11,876,000 | $17.1M | -2,561,000 |
| JD.COM INCJD.COM INC NOTE 0.250% 6/0 | principal | 17,185,000 | $17M | new |
| NUTANIX INCNUTANIX INC NOTE 0.500%12/1 | principal | 16,171,000 | $16M | +12,171,000 |
| ON SEMICONDUCTOR CORPON SEMICONDUCTOR CORP NOTE 0.500% 3/0 | principal | 12,961,000 | $15.7M | -19,634,000 |
| TETRA TECH INC NEWTETRA TECH INC NEW DBCV 2.250% 8/1 | principal | 15,782,000 | $14.6M | +10,898,000 |
| LYFT INCLYFT INC Convertible | principal | 9,900,000 | $10.4M | -9,520,000 |
| JAZZ INVESTMENTS I LTDJAZZ INVESTMENTS I LTD Convertible | principal | 7,500,000 | $10.1M | +2,000,000 |
| WORLD KINECT CORPORATIONWORLD KINECT CORPORATION Convertible | principal | 9,170,000 | $10M | +1,996,000 |
| LIVE NATION ENTERTAINMENT INLIVE NATION ENTERTAINMENT IN Convertible | principal | 8,690,000 | $9.84M | +4,090,000 |
| PPL CAP FDG INCPPL CAP FDG INC NOTE 2.875% 3/1 | principal | 8,480,000 | $9.51M | -769,000 |
| BIOMARIN PHARMACEUTICAL INCBIOMARIN PHARMACEUTICAL INC NOTE 1.250% 5/1 | principal | 9,624,000 | $9.37M | +5,609,000 |
| CHEESECAKE FACTORY INCCHEESECAKE FACTORY INC NOTE 2.000% 3/1 | principal | 9,000,000 | $8.91M | +3,000,000 |
| FLUOR CORPFLUOR CORP NOTE 1.125% 8/1 | principal | 7,645,000 | $7.96M | +3,450,000 |
| LCI INDSLCI INDS Convertible | principal | 7,200,000 | $7.95M | -1,000,000 |
| AMPHASTAR PHARMACEUTICALS INAMPHASTAR PHARMACEUTICALS IN NOTE 2.000% 3/1 | principal | 8,460,000 | $7.69M | -17,566,000 |
| PACIRA BIOSCIENCES INCPACIRA BIOSCIENCES INC NOTE 2.125% 5/1 | principal | 7,522,000 | $7.53M | +303,000 |
| ETSY INCETSY INC NOTE 1.000% 6/1 | principal | 7,735,000 | $7.12M | new |
| COGENT BIOSCIENCES INCCOGENT BIOSCIENCES INC NOTE 1.625%11/1 | principal | 7,250,000 | $6.47M | +2,625,000 |
| ALLIANT ENERGY CORPALLIANT ENERGY CORP NOTE 3.250% 5/3 | principal | 6,500,000 | $5.46M | new |
| ALARM COM HLDGS INCALARM COM HLDGS INC NOTE 2.250% 6/0 | principal | 5,626,000 | $5.38M | -23,000 |
| COLLEGIUM PHARMACEUTICAL INCCOLLEGIUM PHARMACEUTICAL INC NOTE 2.875% 2/1 | principal | 5,725,000 | $4.57M | +1,600,000 |
| POST HLDGS INCPOST HLDGS INC NOTE 2.500% 8/1 | principal | 5,750,000 | $4.45M | +1,750,000 |
| SOUTHERN COSOUTHERN CO NOTE 4.500% 6/1 | principal | 4,500,000 | $4.4M | 0 |
| CELCUITY INCCELCUITY INC Convertible | principal | 3,500,000 | $3.18M | new |
| REVOLUTION MEDICINES INCREVOLUTION MEDICINES INC NOTE 0.500% 5/0 | principal | 2,570,000 | $2.86M | new |
| NUVATION BIO INCNUVATION BIO INC NOTE 0.750% 7/0 | principal | 3,500,000 | $2.69M | new |
| IMMUNOCORE HLDGS PLCIMMUNOCORE HLDGS PLC NOTE 2.500% 2/0 | principal | 4,150,000 | $2.2M | 0 |
| AKAMAI TECHNOLOGIES INCAKAMAI TECHNOLOGIES INC NOTE 1.125% 2/1 | principal | 1,594,000 | $1.86M | -15,556,000 |
| BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 1.750% 3/0 | principal | 275,000 | $463K | +150,000 |
| UBER TECHNOLOGIES INCUBER TECHNOLOGIES INC NOTE 0.875%12/0 | principal | 375,000 | $451K | new |
| ANI PHARMACEUTICALS INCANI PHARMACEUTICALS INC NOTE 2.250% 9/0 | principal | 250,000 | $325K | new |
| LIBERTY MEDIA CORP DELLIBERTY MEDIA CORP DEL NOTE 2.250% 8/1 | principal | 250,000 | $316K | new |
| CYBERARK SOFTWARE LTDCYBERARK SOFTWARE LTD NOTE6/1 | principal | 175,000 | $299K | new |
| TRANSMEDICS GROUP INCTRANSMEDICS GROUP INC NOTE 1.500% 6/0 | principal | 250,000 | $274K | new |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| VISHAY INTERTECHNOLOGY INCVISHAY INTERTECHNOLOGY INC | 41,311,000 | $39.6M | principal |
| SHIFT4 PMTS INCSHIFT4 PMTS INC | 31,386,000 | $29.5M | principal |
| SPECTRUM BRANDS INCSPECTRUM BRANDS INC | 9,290,000 | $9.19M | principal |
| ARRAY TECHNOLOGIES INCARRAY TECHNOLOGIES INC | 7,369,000 | $6.69M | principal |
| CENTERPOINT ENERGY INCCENTERPOINT ENERGY INC | 3,662,000 | $4.35M | principal |
| WEC ENERGY GROUP INCWEC ENERGY GROUP INC | 3,000,000 | $1.82M | principal |
| BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC | 210,000 | $237K | principal |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001533551-26-000004 | base | 2026-08-13 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001533551-26-000004 | Quarter ended 2026-06-30 | 2026-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-26-000003 | Quarter ended 2026-03-31 | 2026-05-11 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001533551-26-000002 | Quarter ended 2025-12-31 | 2026-02-06 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-26-000001 | Quarter ended 2025-12-31 | 2026-02-06 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-25-000006 | Quarter ended 2025-09-30 | 2025-10-21 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-25-000004 | Quarter ended 2025-06-30 | 2025-08-05 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-25-000002 | Quarter ended 2025-03-31 | 2025-05-02 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-25-000001 | Quarter ended 2024-12-31 | 2025-01-27 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-24-000005 | Quarter ended 2024-09-30 | 2024-10-23 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-24-000004 | Quarter ended 2024-06-30 | 2024-08-07 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-24-000003 | Quarter ended 2024-03-31 | 2024-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-24-000002 | Quarter ended 2023-12-31 | 2024-02-09 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-23-000004 | Quarter ended 2023-09-30 | 2023-11-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001533551-23-000005 | Quarter ended 2023-09-30 | 2023-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-23-000003 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-23-000002 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-23-000001 | Quarter ended 2022-12-31 | 2023-02-10 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-22-000005 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-22-000004 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-22-000003 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-22-000002 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-21-000007 | Quarter ended 2021-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-21-000004 | Quarter ended 2021-06-30 | 2021-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-21-000003 | Quarter ended 2021-03-31 | 2021-05-11 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001533551-21-000002 | Quarter ended 2020-12-31 | 2021-03-01 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-21-000001 | Quarter ended 2020-12-31 | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-20-000004 | Quarter ended 2020-09-30 | 2020-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-20-000003 | Quarter ended 2020-06-30 | 2020-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-20-000002 | Quarter ended 2020-03-31 | 2020-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-20-000001 | Quarter ended 2019-12-31 | 2020-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-19-000007 | Quarter ended 2019-09-30 | 2019-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-19-000003 | Quarter ended 2019-06-30 | 2019-08-09 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-19-000002 | Quarter ended 2019-03-31 | 2019-05-07 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-19-000001 | Quarter ended 2018-12-31 | 2019-02-07 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-18-000004 | Quarter ended 2018-09-30 | 2018-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-18-000003 | Quarter ended 2018-06-30 | 2018-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-18-000002 | Quarter ended 2018-03-31 | 2018-05-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-18-000001 | Quarter ended 2017-12-31 | 2018-02-09 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-17-000004 | Quarter ended 2017-09-30 | 2017-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-17-000003 | Quarter ended 2017-06-30 | 2017-08-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-17-000002 | Quarter ended 2017-03-31 | 2017-05-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-17-000001 | Quarter ended 2016-12-31 | 2017-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-16-000010 | Quarter ended 2016-09-30 | 2016-11-10 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-16-000009 | Quarter ended 2016-06-30 | 2016-08-10 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-16-000006 | Quarter ended 2016-03-31 | 2016-05-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-16-000005 | Quarter ended 2015-12-31 | 2016-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-15-000004 | Quarter ended 2015-09-30 | 2015-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-15-000003 | Quarter ended 2015-06-30 | 2015-08-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-15-000002 | Quarter ended 2015-03-31 | 2015-05-08 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-15-000001 | Quarter ended 2014-12-31 | 2015-02-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-14-000005 | Quarter ended 2014-09-30 | 2014-11-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-14-000004 | Quarter ended 2014-06-30 | 2014-08-11 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-14-000003 | Quarter ended 2014-03-31 | 2014-05-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001533551-14-000002 | Quarter ended 2013-12-31 | 2014-03-25 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-14-000001 | Quarter ended 2013-12-31 | 2014-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-13-000008 | Quarter ended 2013-09-30 | 2013-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001533551-13-000005 | Quarter ended 2013-06-30 | 2013-08-13 | acceptance time not in the bulk data set |